Sanofi Divests 16 Brands From European Consumer Healthcare Portfolio

By Kim Richters

Sanofi SA said Monday that it has agreed to sell some brands from its consumer healthcare portfolio in Europe to STADA Arzneimittel AG in an effort to streamline the section.

The French pharmaceutical company said the agreement covers registrations, trademarks and related commercial rights for 16 products in Europe.

Sanofi said it doesn't expect its European staff to be affected on account of the deal, which it assumes will close in the third quarter of this year.

In a separate release, Germany-based STADA said the deal includes products like the cough remedies Silomat and the skincare range Viscontour. It said most of the portfolio's annual turnover was currently generated in Germany, France, Spain, Italy and Poland.

The companies didn't disclose financial terms of the agreement.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

June 28, 2021 02:35 ET (06:35 GMT)

Stada Arzneimi Namen (CE) (USOTC:STDAF)
Historical Stock Chart
From May 2024 to Jun 2024